Sign in
4

Changes in Ownership

Tonix Pharmaceuticals Holding Corp. Filed Acc 0001144204-14-074480

Chief Financial Officer acquired 3,530 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GERSHELL LELAND · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2014-12-17 Option exercise : show line 1 in the form +3,530 $4.25 $15,003 12,860 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2014-12-17 Option exercise : show line 2 in the form Series A common stock purchase warrant −3,530 0 D
Loading xslF345X03/v396885_form4.xml…